May 2005

 

Issue

An Interview With Anne C. Roberts, MD

By Anne C. Roberts, MD

CODING & REIMBURSEMENT

Carotid Artery Stenting

A perspective on the CMS decision memo regarding CAS.

By Kieran P. Murphy, MD

Provisional Stenting of the Iliac Arteries

This technique may provide a more cost-effective and patient-specific option.

By John H. Rundback, MD

Primary Stenting of the Iliac Artery

Recent developments in technology have made primary stenting an attractive option.

By Gary M. Ansel, MD

Do the TASC Guidelines Still Apply?

Current available data suggest that an adjustment may be necessary.

By Dierk Scheinert, MD

COVER STORY

Clinical Evaluation and Diagnosis of Iliac Disease

Optimal use of today’s imaging options combined with an elevated index ofsuspicion enables results in early detection and successful treatment.

By Michael R. Jaff, DO

Treating Iliac Aneurysms

Two devices are currently being evaluated for treating patients with iliac aneurysmal disease.

By Zvonimir Krajcer, MD

Iliac Surgical Options

When is surgery still the best option for aortoiliac occlusive disease?

By David H. Stone, MD, and Richard P. Cambria, MD

Iliac CPT Coding

An iliac is not an iliac is not an iliac.

By Roseanne R. Wholey

Complications After Iliac Artery Interventions

An overview of the complications associated with treating iliac arteries.

By M. Habeeb Ahmed, MD, RVT; Aravinda Nanjundappa, MD; and John R. Laird, Jr, MD

DEPARTMENTS

Custom Devices

Clarification of the FDA definition of custom devices.

By Dorothy B. Abel, with Harold Pellerite

CHALLENGING CASE

Percutaneous Removal of a Misplaced “Permanent” LGM Vena Tech Filter

An incorrectly placed filter is retrieved before it migrates to the heart.

By Eyal Barzel, MD, and James McGuckin, MD

UP FRONT

Iliac Artery Interventions

By John R. Laird, Jr, MD

SOCIETY UPDATE

The PVSS

An update of the history and future of the Peripheral Vascular Surgery Society.

By Lewis B. Schwartz, MD, and Robert G. Scribner, MD

PHARMACOLOGY

Bivalirudin in Peripheral Interventions

Results from the APPROVE trial and the emerging role of “endopharmacology” in treating PVD.

By David E. Allie, MD; Patrick A. Hall, MD; Nicolas W. Shammas, MD; Robert Safian, MD; John R. Laird, Jr, MD; John J. Young, MD; and Ajay Virmani, MD
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.